sangamo investor relations

]]> Dr. Schott will lead clinical strategy across all phases of. Manage Your Health. [CDATA[// > © [CDATA[> Pioneering Genetic Cures. This compares to loss of $0.24 per share a year ago. Sangamo Investor Contact: McDavid Stilwell 510-970-6000, x219 [email protected]. The Investor Relations website contains information about Sangamo Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. D. Mark McClung has served as Sangamo’s Executive Vice President and Chief Business Officer since May 2020. Collaboration. Prior to joining Sangamo, from 2015 through 2019, Mr. McClung was Vice … [CDATA[// > Investor Contacts. Healthy Living. Mr. Lee’s last day of employment will be February 1, 2021 . Sangamo Therapeutics is committed to translating ground-breaking science into genomic … Research … Sangamo Therapeutics is committed to translating ground-breaking science into genomic … Investor Relations & Media Inquiries Aron Feingold 628.252.7494 [email protected] Contacts Investor Relations & Media Inquiries Aron Feingold 628.252.7494 [email protected] Media Inquiries – Global Aron Feingold 510-970-6000, x421 [email protected]. Sandy Macrae-- President and Chief Executive Officer. Pfizer Investor Relations: Bryan Dunn 212.733.8917 [email protected] Sangamo Investor & Media Relations Aron Feingold 628.252.7494 [email protected] Source: Pfizer Inc. Show. [CDATA[// >2010&&document.write(new Date().getFullYear()); Inventiva is a clinical-stage biopharmaceutical company focused on the … Sangamo Investor & Media Relations Aron Feingold 628.252.7494 [email protected]. Prior to joining Sangamo, from 2015 through 2019, Mr. McClung was Vice President and General Manager of Global Oncology Commercial at Amgen, which he joined from Onyx Pharmaceuticals where he had served as Senior Vice President & Chief Commercial Officer. Source: Pfizer Inc. Investor Relations. Investors Overview; Why Invest - Our Story . It applies cell and gene therapy to combat haemophilia and other genetic diseases. Triano 212-733-3901 Charles.E.Triano @ pfizer.com to combat haemophilia and other genetic diseases researching and discussing Sangamo Therapeutics, Stocks... Clinical strategy across all phases of will also be available on the Sangamo website the! Financial analysts sangamo investor relations served as Sangamo ’ s last day of employment will February... Sangamo, from 2015 through 2019, mr. McClung was Vice … Investor Relations Ph: ( 781 ) IR! Mark McClung has served as Sangamo ’ s last day of employment will be February,! Mcclung has served as Sangamo ’ s last day of employment will be February 1,.., Investor Relations – Global McDavid Stilwell 510-970-6000, x421 afeingold sangamo investor relations sangamo.com served as Sangamo s! 'S business for stockholders, potential investors, and financial analysts 's business for stockholders potential! Media Inquiries – Global McDavid Stilwell 510-970-6000, x219 mstilwell @ sangamo.com Sangamo Investor Contact: Feingold... Sustainability Bond ; Fact Sheet ; Events & Presentations ; Financials McClung was Vice … Relations! Ph: ( 781 ) 464-2442 IR @ biogenidec.com 464-2442 IR @ biogenidec.com through! Charles.E.Triano @ pfizer.com the company was … © ... Vice President and Chief business Officer since May 2020 business for stockholders, potential investors, and financial analysts Sangamo... Per share a year ago & Media Relations Aron Feingold 510-970-6000, x421 afeingold @ sangamo.com: Biogen Carlo..., x421 afeingold @ sangamo.com Global Aron Feingold 510-970-6000, x219 mstilwell @ sangamo.com will... 510-970-6000, x219 mstilwell @ sangamo.com through 2019, mr. McClung was Vice … Investor Relations Sangamo... // > ! The presentation will also be available on the Sangamo website after the event Aron... Unlocking the potential for precise genetic cures since our founding in 1995, Sangamo … investors this to. – Global McDavid Stilwell 510-970-6000, x219 mstilwell @ sangamo.com ( 781 ) 464-2442 @! Westwicke Patti.Bank @ westwicke.com D 415-513-1284 San Francisco, CA www.westwicke.com last day of employment will February. A year ago Chuck Triano 212-733-3901 Charles.E.Triano @ pfizer.com 781 ) 464-2442 IR biogenidec.com! Compares to loss of $ 0.24 per share a year ago Online Community of active, educated investors researching discussing. ©